| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abenoku, Osaka, 545–8585, Japan
Correspondence to:
Correspondence to:
Dr H Kanazawa, Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abenoku, Osaka, 545–8585, Japan;
kanazawa-h{at}med.osaka-cu.ac.jp
Background: There is evidence that the bronchial microcirculation has the potential to contribute to the pathophysiological mechanisms of exercise induced bronchoconstriction (EIB) in asthmatic subjects. Vascular endothelial growth factor (VEGF), which is highly expressed in asthmatic airways, increases vascular permeability. The relationship between VEGF levels in induced sputum and the severity of EIB in asthmatic subjects was studied.
Methods: The concentration of VEGF in induced sputum was examined in 23 asthmatic subjects and 11 normal controls. The asthmatic subjects performed an exercise test and the % maximal fall in forced expiratory volume in 1 second (FEV1) was measured. Beclomethasone dipropionate (BDP) 400 µg twice daily was administered to the asthmatic subjects for 8 weeks and the exercise test and sputum induction were repeated.
Results: The concentration of VEGF in induced sputum was significantly higher in asthmatic subjects than in normal controls. There was a significant correlation between the concentration of VEGF and the % maximal fall in FEV1 (r=0.826, p=0.0001) and between the concentration of VEGF and airway vascular permeability index (r=0.621, p=0.0037). After treatment with inhaled BDP there was a significant decrease in the concentration of VEGF in the asthmatic subjects (before treatment: 7051 (2361) pg/ml, after treatment: 4498 (2135) pg/ml, p<0.0001). The change in the concentration of VEGF was significantly correlated with the change in the % maximal fall in FEV1 (r=0.463, p=0.031).
Conclusions: Excessive production of VEGF in asthmatic airways may contribute to the pathogenesis of EIB via increased airway vascular permeability.
Keywords: vascular endothelial growth factor; exercise induced bronchoconstriction; bronchial asthma
This article has been cited by other articles:
|
|
 |
|
  R. L. Clifford, K. Deacon, and A. J. Knox Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor {beta}1: REQUIREMENT FOR Smads, {beta}-CATENIN, AND GSK3{beta} J. Biol. Chem., December 19, 2008; 283(51): 35337 - 35353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Simcock, V. Kanabar, G. W. Clarke, K. Mahn, C. Karner, B. J. O'Connor, T. H. Lee, and S. J. Hirst Induction of Angiogenesis by Airway Smooth Muscle From Patients with Asthma Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 460 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kanazawa and T. Yoshikawa Up-Regulation of Thrombin Activity Induced by Vascular Endothelial Growth Factor in Asthmatic Airways Chest, October 1, 2007; 132(4): 1169 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Hasaneen, S. Zucker, R. Z. Lin, G. G. Vaday, R. A. Panettieri, and H. D. Foda Angiogenesis is induced by airway smooth muscle strain Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1059 - L1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Simcock, V. Kanabar, G. W. Clarke, B. J. O'Connor, T. H. Lee, and S. J. Hirst Proangiogenic Activity in Bronchoalveolar Lavage Fluid from Patients with Asthma Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 146 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanazawa, S. Nomura, and K. Asai Roles of Angiopoietin-1 and Angiopoietin-2 on Airway Microvascular Permeability in Asthmatic Patients Chest, April 1, 2007; 131(4): 1035 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Knox, K. Deacon, and R. Clifford Blanching the airways: steroid effects in asthma Thorax, April 1, 2007; 62(4): 283 - 285. [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Shin, C. D. Schwindt, A. S. Aledia, C. M. Rose-Gottron, J. K. Larson, R. L. Newcomb, D. M. Cooper, and S. C. George Exercise-induced bronchoconstriction alters airway nitric oxide exchange in a pattern distinct from spirometry Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1741 - R1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bhandari, R. Choo-Wing, S. P. Chapoval, C. G. Lee, C. Tang, Y. K. Kim, B. Ma, P. Baluk, M. I. Lin, D. M. McDonald, et al. Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung PNAS, July 18, 2006; 103(29): 11021 - 11026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Lee, K. H. Min, S. R. Kim, S. J. Park, H. S. Park, G. Y. Jin, and Y. C. Lee Vascular Endothelial Growth Factor Modulates Matrix Metalloproteinase-9 Expression in Asthma Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 161 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. O. Abdel-Rahman, S. A. F. El-Sahrigy, and S. I. Bakr A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest, February 1, 2006; 129(2): 266 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder Vascular endothelial growth factor in the lung Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Horvath and A. Wanner Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Eur. Respir. J., January 1, 2006; 27(1): 172 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bradbury, D. Clarke, C. Seedhouse, L. Corbett, J. Stocks, and A. Knox Vascular Endothelial Growth Factor Induction by Prostaglandin E2 in Human Airway Smooth Muscle Cells Is Mediated by E Prostanoid EP2/EP4 Receptors and SP-1 Transcription Factor Binding Sites J. Biol. Chem., August 26, 2005; 280(34): 29993 - 30000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J Knox, J Stocks, and A Sutcliffe Angiogenesis and vascular endothelial growth factor in COPD Thorax, February 1, 2005; 60(2): 88 - 89. [Full Text] [PDF]
|
|
|
|
|
|
N. C. Thomson and R. Chaudhuri Why Is Eosinophilic Bronchitis not Asthma? Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 4 - 5. [Full Text] [PDF]
|
|
|
|
|
|
H. Kanazawa, S. Nomura, and J. Yoshikawa Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1125 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanazawa, T. Yoshikawa, K. Hirata, and J. Yoshikawa Effects of Pranlukast Administration on Vascular Endothelial Growth Factor Levels in Asthmatic Patients Chest, May 1, 2004; 125(5): 1700 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Feistritzer, N. C. Kaneider, D. H. Sturn, B. A. Mosheimer, C. M. Kahler, and C. J. Wiedermann Expression and Function of the Vascular Endothelial Growth Factor Receptor FLT-1 in Human Eosinophils Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 729 - 735. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
